Tivantinib Hampers the Proliferation of Glioblastoma Cells via PI3K/Akt/Mammalian Target of Rapamycin (mTOR) Signaling-MedSci.cn

Tivantinib Hampers the Proliferation of Glioblastoma Cells via PI3K/Akt/Mammalian Target of Rapamycin (mTOR) Signaling

Wu, YK; Li, ZZ; Zhang, LJ; Liu, GY

Zhang, LJ (reprint author), Linyi Cent Hosp, Dept Cardiovasc Med, Yishui, Shandong, Peoples R China.; Liu, GY (reprint author), Jinan Fourth Peoples Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China.

MEDICAL SCIENCE MONITOR, 2019; 25 (): 7383

Abstract

Background: Glioblastoma, the most common and malignant glial tumor, often has poor prognosis. Tivantinib has shown its potential in treating c-Met-hi......

Full Text Link